EC approves eslicarbazepine acetate monotherapy for newly diagnosed partial-onset epilepsy June 26, 2017
Merck KGaA's cladribine earns positive opinion from CHMP for relapsing forms of multiple sclerosis June 26, 2017
EMA's CHMP grants positive opinion for tivozanib for the first-line treatment of advanced RCC June 26, 2017
Alexion Pharmaceuticals receives positive opinion from EMA to extend Soliris indication June 26, 2017
RSS